Roche Holding reported CHF13.34B in Trade Debtors for its fiscal semester ending in June of 2026.





Trade Debtors Change Date
AbbVie USD 13.82B 1.34B Jun/2026
Alcon AG USD 2.06B 35M Sep/2026
Almirall EUR 196.15M 20.22M Jun/2026
Amgen USD 10.35B 126M Sep/2026
AstraZeneca USD 18.87B 11M Sep/2026
Bayer EUR 17.41B 1.29B Sep/2026
Biogen USD 2.38B 15.8M Sep/2026
Bristol-Myers Squibb USD 12.85B 976M Sep/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Fresenius EUR 4.89B 250M Sep/2026
Fresenius Medical Care EUR 3.45B 15.38M Sep/2026
Genmab DKK 1.22B 192M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.52B 451M Sep/2026
GRIFOLS EUR 1.08B 110M Sep/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Lakefront Biotherapeutics EUR 147.02M 2.44M Sep/2026
Lonza CHF 1.78B 55M Dec/2025
Merck EUR 4.89B 66M Sep/2026
Merck USD 12.56B 354M Jun/2026
Novartis USD 9.96B 109M Sep/2026
Orion EUR 543.8M 155.8M Jun/2026
Pfizer USD 17.57B 1.38B Sep/2026
Philips EUR 3.62B 19M Sep/2026
Recordati EUR 769.35M 9.36M Sep/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Sanofi EUR 326M 166M Sep/2026
UCB EUR 1.97B 54M Dec/2025